{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"febrile-infection-related-epilepsy","columns":[{"gene":"","key":"population-59b6d383095ff384efe2","label":"Febrile infection-related epilepsy syndrome","mondoId":"MONDO:0015584","onsetQualifier":null,"originColumnKey":"MONDO:0015584/ORPHA:163703","originalViews":[{"key":"MONDO:0015584/ORPHA:163703","label":"Febrile infection-related epilepsy syndrome","scopeLabel":"ORPHA:163703","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0a92def3ae98ed26025e834bb898de4c22f7c11234b9a57684c9f5c575b681d4","171c77b0daa5e5afc43004bc5f543e9aae39cb0ebcff1d0fa19ed376659bbdee","17da708ef3861e9b74ef6a15c1c05f7a1f32511251efd6513304352da5a7da67","1e4854768738cfa4d3f61a80a7505b13fbb9f5ba1cd69cece7d00c4bdd3a647e","450df11c3cab1176358f21d73669ed426d208f7f3d690c56f633ccebffa8872e","51112f63db909887272bb6d464a20fb1734606595518979ab1a861739071e001","60641403f4adbec54262cf2fec40ae154a2c21dd783532784f56a67b9a23980a","6f955f3461efcfe98f4ef7fbf603338d8e3edc9c960ecb0b48c50afd0f26a349","7944be2b5d2ac7e1caa491b916af4e2a140ae5fdcfb3d1273bb197e728e19b4f","a1bb92649cb80958d1b3698f23a86756663f722b53722416ed6a3397a37f1e30","f5fc090180da95f128f4e7796140c5da95ab191851b8acd6b04d9f559663751f","fe9e036ced67fb26d3ec644c63b2a4409902f8308b739ea57ad790ff27967617"],"recordQualifiers":{},"scopeLabel":"ORPHA:163703","sourceIds":["ORPHA:163703"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-59b6d383095ff384efe2"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0000708","HP:0002960","HP:0012735","HP:0002376","HP:0002353","HP:0001945","HP:0007359"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":12,"sourceGroups":{"orphanet":12}},"features":[{"hpoId":"HP:0000708","label":"Atypical behavior","primary":true},{"hpoId":"HP:0002960","label":"Autoimmunity","primary":true},{"hpoId":"HP:0012735","label":"Cough","primary":true},{"hpoId":"HP:0002376","label":"Developmental regression","primary":true},{"hpoId":"HP:0002353","label":"EEG abnormality","primary":true},{"hpoId":"HP:0001945","label":"Fever","primary":true},{"hpoId":"HP:0007359","label":"Focal-onset seizure","primary":true},{"hpoId":"HP:0002315","label":"Headache","primary":false},{"hpoId":"HP:0001254","label":"Lethargy","primary":false},{"hpoId":"HP:0003326","label":"Myalgia","primary":false},{"hpoId":"HP:0000246","label":"Sinusitis","primary":false},{"hpoId":"HP:0001699","label":"Sudden death","primary":false}],"ledeHtml":"FIRES (Febrile infection-related epilepsy syndrome) is a sub-type of cryptogenic new-onset refractory status epilepticus (NORSE). NORSE describes a condition in which a healthy person who has not had seizures before, begins having seizures. Over a few days, the seizures increase in frequency and length and evolve into status epilepticus (SE). SE is a prolonged seizure or cluster of seizures during which a person does not regain consciousness between seizures. The seizure activity is considered refractory because it cannot be controlled with standard anti-seizure medications. Cryptogenic means all possible known causes have been ruled out. People with the sub-type FIRES have a fever a day to two weeks before the beginning of the seizures. The fever may or may not be present when SE begins, but no infection can be found to be causing SE. SE can last for days, weeks, or even months. Of note, FIRES previously was considered a separate condition that occurred only in children, while NORSE was described only in adults. However, there is now consensus that FIRES and NORSE without a prior fever can both be described in people of any age.","mondoId":"MONDO:0015584","node":{"canonicalSlug":"febrile-infection-related-epilepsy","comparisons":[{"documentSha256":"992d2f349571099f80e836b952256841f36fd8da595ed7c2cf562240df78df72","key":"legacy-febrile-infection-related-epilepsy","kind":"legacy","label":"febrile infection-related epilepsy syndrome","memberIds":["MONDO:0015584"],"mondoId":"MONDO:0015584","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/febrile-infection-related-epilepsy.992d2f349571099f80e836b952256841f36fd8da595ed7c2cf562240df78df72.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Febrile infection-related epilepsy syndrome","originalSourceId":"ORPHA:163703","paragraphs":["FIRES (Febrile infection-related epilepsy syndrome) is a sub-type of cryptogenic new-onset refractory status epilepticus (NORSE). NORSE describes a condition in which a healthy person who has not had seizures before, begins having seizures. Over a few days, the seizures increase in frequency and length and evolve into status epilepticus (SE). SE is a prolonged seizure or cluster of seizures during which a person does not regain consciousness between seizures. The seizure activity is considered refractory because it cannot be controlled with standard anti-seizure medications. Cryptogenic means all possible known causes have been ruled out. People with the sub-type FIRES have a fever a day to two weeks before the beginning of the seizures. The fever may or may not be present when SE begins, but no infection can be found to be causing SE. SE can last for days, weeks, or even months. Of note, FIRES previously was considered a separate condition that occurred only in children, while NORSE was described only in adults. However, there is now consensus that FIRES and NORSE without a prior fever can both be described in people of any age."],"rawAttribution":"MONDO:0015584","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T16:59:27Z","upstream":"GARD:0011005","url":"https://rarediseases.info.nih.gov/diseases/11005"},"ownColumnKeys":["population-59b6d383095ff384efe2"],"publication":"published","relationships":[{"kind":"parent","label":"childhood-onset epilepsy syndrome with developmental and/or epileptic encephalopathy","mondoId":"MONDO:0800500","slug":"childhood-onset-epilepsy-syndrome-with-developmental-and-or-epileptic-encephalopathy"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"0a92def3ae98ed26025e834bb898de4c22f7c11234b9a57684c9f5c575b681d4","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:163703","disease_name":"Febrile infection-related epilepsy syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002376","is_excluded":false,"label":"Developmental regression","onset_id":null,"reference":"ORPHA:163703","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"171c77b0daa5e5afc43004bc5f543e9aae39cb0ebcff1d0fa19ed376659bbdee","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:163703","disease_name":"Febrile infection-related epilepsy syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000708","is_excluded":false,"label":"Atypical behavior","onset_id":null,"reference":"ORPHA:163703","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"17da708ef3861e9b74ef6a15c1c05f7a1f32511251efd6513304352da5a7da67","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:163703","disease_name":"Febrile infection-related epilepsy syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002315","is_excluded":false,"label":"Headache","onset_id":null,"reference":"ORPHA:163703","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"1e4854768738cfa4d3f61a80a7505b13fbb9f5ba1cd69cece7d00c4bdd3a647e","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:163703","disease_name":"Febrile infection-related epilepsy syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001254","is_excluded":false,"label":"Lethargy","onset_id":null,"reference":"ORPHA:163703","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"450df11c3cab1176358f21d73669ed426d208f7f3d690c56f633ccebffa8872e","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:163703","disease_name":"Febrile infection-related epilepsy syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002353","is_excluded":false,"label":"EEG abnormality","onset_id":null,"reference":"ORPHA:163703","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"51112f63db909887272bb6d464a20fb1734606595518979ab1a861739071e001","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:163703","disease_name":"Febrile infection-related epilepsy syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012735","is_excluded":false,"label":"Cough","onset_id":null,"reference":"ORPHA:163703","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"60641403f4adbec54262cf2fec40ae154a2c21dd783532784f56a67b9a23980a","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:163703","disease_name":"Febrile infection-related epilepsy syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002960","is_excluded":false,"label":"Autoimmunity","onset_id":null,"reference":"ORPHA:163703","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6f955f3461efcfe98f4ef7fbf603338d8e3edc9c960ecb0b48c50afd0f26a349","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:163703","disease_name":"Febrile infection-related epilepsy syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001699","is_excluded":false,"label":"Sudden death","onset_id":null,"reference":"ORPHA:163703","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7944be2b5d2ac7e1caa491b916af4e2a140ae5fdcfb3d1273bb197e728e19b4f","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:163703","disease_name":"Febrile infection-related epilepsy syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000246","is_excluded":false,"label":"Sinusitis","onset_id":null,"reference":"ORPHA:163703","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a1bb92649cb80958d1b3698f23a86756663f722b53722416ed6a3397a37f1e30","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:163703","disease_name":"Febrile infection-related epilepsy syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0007359","is_excluded":false,"label":"Focal-onset seizure","onset_id":null,"reference":"ORPHA:163703","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f5fc090180da95f128f4e7796140c5da95ab191851b8acd6b04d9f559663751f","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:163703","disease_name":"Febrile infection-related epilepsy syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003326","is_excluded":false,"label":"Myalgia","onset_id":null,"reference":"ORPHA:163703","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"fe9e036ced67fb26d3ec644c63b2a4409902f8308b739ea57ad790ff27967617","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:163703","disease_name":"Febrile infection-related epilepsy syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001945","is_excluded":false,"label":"Fever","onset_id":null,"reference":"ORPHA:163703","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/11005\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0015584\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0011005</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>FIRES (Febrile infection-related epilepsy syndrome) is a sub-type of cryptogenic new-onset refractory status epilepticus (NORSE). NORSE describes a condition in which a healthy person who has not had seizures before, begins having seizures. Over a few days, the seizures increase in frequency and length and evolve into status epilepticus (SE). SE is a prolonged seizure or cluster of seizures during which a person does not regain consciousness between seizures. The seizure activity is considered refractory because it cannot be controlled with standard anti-seizure medications. Cryptogenic means all possible known causes have been ruled out. People with the sub-type FIRES have a fever a day to two weeks before the beginning of the seizures. The fever may or may not be present when SE begins, but no infection can be found to be causing SE. SE can last for days, weeks, or even months. Of note, FIRES previously was considered a separate condition that occurred only in children, while NORSE was described only in adults. However, there is now consensus that FIRES and NORSE without a prior fever can both be described in people of any age.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/11005\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"febrile-infection-related-epilepsy","sourceDocuments":[{"name":"GARD: Febrile infection-related epilepsy syndrome","reviewed":null,"source_release":"2026-10-21T16:59:27Z","url":"https://rarediseases.info.nih.gov/diseases/11005"},{"name":"MONDO: febrile infection-related epilepsy syndrome","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0015584"}],"sourceNote":"","synonyms":["acute encephalitis with refractory repetitive partial seizures","acute non-herpetic encephalitis with severe refractory status epilepticus","AERRPS","DESC syndrome","devastating epileptic encephalopathy in school-aged children","Febrile Infection-Related Epilepsy Syndrome (FIRES)","fever-induced refractory epileptic encephalopathy in school-aged children","FIRES","idiopathic catastrophic epileptic encephalopathy","severe refractory status epilepticus owing to presumed encephalitis","status epilepticus owing to presumed encephalitis"],"takeawayHtml":"","title":"febrile infection-related epilepsy syndrome"},"schemaVersion":1}
